- Strategic Portfolio Management through Sector-Specific Investments
- 2 Coins to 15x Your $500 Portfolio Into $7,500 Long Before Dogecoin (DOGE) Explodes to $2
- Are these 3 Top-Ranked Mutual Funds In Your Retirement Portfolio?
- Plymouth Industrial REIT Expands Cincinnati Footprint with $38M Strategic Portfolio Acquisition
- 5 Momentum Stocks Investors Can Add to Boost Portfolio Returns in 2025 – December 24, 2024
As global markets navigate a mixed start to the new year, with U.S. indices reflecting both gains and challenges, investors are keenly observing economic indicators such as the Chicago PMI and GDP forecasts for insights into future trends. Amidst this backdrop of cautious optimism and strategic adjustments, growth companies with high insider ownership present intriguing opportunities due to their potential alignment of management interests with shareholder value.
Bạn đang xem: Top 3 Insider-Owned Growth Stocks For Your Portfolio
Name |
Insider Ownership |
Earnings Growth |
SKS Technologies Group (ASX:SKS) |
29.7% |
24.8% |
Propel Holdings (TSX:PRL) |
23.8% |
37.6% |
CD Projekt (WSE:CDR) |
29.7% |
27% |
Medley (TSE:4480) |
34% |
31.7% |
Pharma Mar (BME:PHM) |
11.8% |
56.2% |
Plenti Group (ASX:PLT) |
12.8% |
120.1% |
EHang Holdings (NasdaqGM:EH) |
31.4% |
79.6% |
Brightstar Resources (ASX:BTR) |
16.2% |
84.5% |
Elliptic Laboratories (OB:ELABS) |
26.8% |
111.4% |
Findi (ASX:FND) |
34.8% |
112.9% |
Underneath we present a selection of stocks filtered out by our screen.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Zhejiang Xiantong Rubber&Plastic Co., Ltd specializes in the research, design, production, and sale of automobile parts in China and has a market capitalization of approximately CN¥3.53 billion.
Xem thêm : High Growth Tech Stocks To Watch For Potential Portfolio Enhancement
Operations: The company generates revenue primarily from its automotive parts segment, amounting to CN¥1.17 billion.
Insider Ownership: 32.1%
Earnings Growth Forecast: 31.5% p.a.
Zhejiang Xiantong Rubber & Plastic Ltd. shows promising growth prospects with revenue forecasted to grow at 24.3% annually, outpacing the CN market’s 13.5%. Earnings are expected to rise significantly by 31.47% per year, surpassing market averages. Recent financials highlight a strong performance with net income reaching CNY 129.19 million for nine months in 2024, up from CNY 96.96 million the previous year, despite a dividend not fully covered by free cash flows and low future return on equity forecasts.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Shanghai AoHua Photoelectricity Endoscope Co., Ltd. is a medical device company that focuses on the research, development, manufacture, and sale of electronic endoscopic equipment and other consumables both in China and internationally, with a market cap of CN¥5.21 billion.
Nguồn: https://earnestmoney.skin
Danh mục: News